Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives (Q37732186)

22 August 2017

1 reference

title

Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives (English)

1 reference

22 August 2017

1 reference

Sergey V Anisimov

1

1 reference

22 August 2017

1 January 2009

1 reference

Reviews in the Neurosciences

22 August 2017

1 reference

22 August 2017

20

1 reference

22 August 2017

5-6

1 reference

22 August 2017

347-381

1 reference

Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats

22 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Screening for mammalian neural genes via fluorescence-activated cell sorter purification of neural precursors from Sox1-gfp knock-in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neural transplantation for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Human mesenchymal stem cells express neural genes, suggesting a neural predisposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Ethical issues in neurografting of human embryonic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Levodopa-induced dyskinesia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Producing primate embryonic stem cells by somatic cell nuclear transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Enrichment of neurons and neural precursors from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Stem cell-based therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Ethics. The ISSCR guidelines for human embryonic stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplanted Precursors of Nerve Cells: Their Fate in the Cerebellums of Young Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Isolation of amniotic stem cell lines with potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Culture and characterization of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neurogenesis in the adult human hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Establishment in culture of pluripotential cells from mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Characterization and neural differentiation of fetal lung mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Unfavorable outcome of adrenal medullary transplant for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Immortalization of precursor cells from the mammalian CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

No evidence for new dopaminergic neurons in the adult mammalian substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transformation of human umbilical mesenchymal cells into neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Socializing with the neighbors: stem cells and their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

New human embryonic stem-cell lines--more is better

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Parkinson's disease: the genetics of a heterogeneous disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Stable genetic modification of human embryonic stem cells by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Human embryonic stem cell-derived neural precursors develop into neurons and integrate into the host brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Human embryonic stem cell stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

2-DE proteomic profiling of neuronal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neural precursor cells derived from human embryonic brain retain regional specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

In vitro differentiation of size-sieved stem cells into electrically active neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Autologous transplantation of the cervical sympathetic ganglion into the parkinsonian brain: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Comparison of fresh and cryopreserved porcine ventral mesencephalon cells transplanted in A rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Mesenchymal stem cells: paradoxes of passaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Induction of neuronal markers in bone marrow cells: differential effects of growth factors and patterns of intracellular expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Ablation of tumor-derived stem cells transplanted to the central nervous system by genetic modification of embryonic stem cells with a suicide gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Integral therapeutic potential of bone marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Methods for derivation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Human neural stem cells genetically modified for brain repair in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Putative chromaffin cell survival and enhanced host-derived TH-Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Continuation of neurogenesis in the hippocampus of the adult macaque monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Induction of Neuron-Specific Enolase Promoter and Neuronal Markers in Differentiated Mouse Bone Marrow Stromal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Stem cells for cell therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Clinical observations after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Stem cell therapy for human neurodegenerative disorders-how to make it work

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Brain repair by cell replacement and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Human embryonic stem cells express an immunogenic nonhuman sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Stem cells in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Infectious concerns of cross-species transplantation: xenozoonoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Adult neurogenesis in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Generation of neural crest-derived peripheral neurons and floor plate cells from mouse and primate embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Endometrial regenerative cells: a novel stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Generation of graftable dopaminergic neuron progenitors from mouse ES cells by a combination of coculture and neurosphere methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Directed differentiation of embryonic stem cells: genetic and epigenetic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Multilineage differentiation from human embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Protection of nigral neurons by GDNF-engineered marrow cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line--studies in vitro and after intracerebral grafting in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Differentiation assays of bone marrow-derived Multipotent Adult Progenitor Cell (MAPC)-like cells towards neural cells cannot depend on morphology and a limited set of neural markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Treatment interventions for Parkinson's disease: an evidence based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neural progenitors from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Stem cell therapy for Parkinson's disease: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Failure of transdifferentiation of adult hematopoietic stem cells into neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Bipotent progenitor cell lines from the human CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Caspase inhibition reduces apoptosis and increases survival of nigral transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Directed neuronal differentiation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Investigation of multipotent postnatal stem cells from human periodontal ligament.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Derivation of pluripotent stem cells from cultured human primordial germ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Immunosurgery of mouse blastocyst

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Morula-derived human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Parkinson's disease: medical treatment of moderate to advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Derivation of a diploid human embryonic stem cell line from a mononuclear zygote

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Bone-marrow transplantation (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Bone-marrow transplantation (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Dopamine neuron transplants: electrophysiological unit activity of intrastriatal nigral grafts in freely moving cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Little evidence for developmental plasticity of adult hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Ethical boundary-work in the embryonic stem cell laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Microfluidic sorting of mammalian cells by optical force switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Adrenal to caudate transplantation--postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Neural precursor cells differentiated from mouse embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Dopaminergic differentiation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Establishing procedures for institutional oversight of stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

In vitro differentiation of transplantable neural precursors from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Evidence for neurogenesis in the adult mammalian substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Multilineage cells from human adipose tissue: implications for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

RETRACTED: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

Additive Effects of Caspase Inhibitor and Lazaroid on the Survival of Transplanted Rat and Human Embryonic Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

FETAL DOPAMINE-RICH MESENCEPHALIC GRAFTS IN PARKINSON'S DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.5-6.347

10.1515/REVNEURO.2009.20.5-6.347

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20397620